Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Signs Letter of Intent with Large Multinational Pharmaceutical Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Emblem Corp EMMBF

Healthcare Biotechnology Cannabis
"Emblem Corp is a licensed producer of medical cannabis. It is intended to cultivate and cure cannabis for medicinal use. The group operates in the business segment of production and sale of medical cannabis."


OTCPK:EMMBF - Post by User

Emblem Corp > fair market value
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by QueenNerfertition Jun 21, 2017 9:50am
139 Views
Post# 26386739

RE:RE:RE:fair market value

RE:RE:RE:fair market valueWell they will have their phase 1 buildout complete and operational by then, and the yeild/profits of that will be fully priced in. Super low float here. 20,000kg = 150 million in sales has them above $7 even with some more dilution (which the company said won't be necessary yet)....... There are terms from their latest PP for common shares above $7...... that means their internal targets have that price being attainable based on fundamentals not hype. All in all, common stock and warrants look super cheap.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities